Association of HLA-DRB1*04 gene with Hashimoto’s thyroiditis among Iraqi-Kurdish population in Erbil province
Keywords:Hashimoto’s thyroiditis, HLA-DRB1*04, Hypothyroidism
Background and objective: Hashimoto’s thyroiditis is one of the common autoimmune thyroid diseases with increasing incidence in the general population. It has been suggested that a combination of genetic and environmental factors increase the risk of developing the disease. The current study aimed to find the association between HLA-DRB1*04 gene with Hashimoto's Thyroiditis among the Iraqi-Kurdish population in Erbil Province.
Methods: The case-control study was conducted on 45 untreated patients with Hashimoto’s thyroiditis who have already been diagnosed and 45 control subjects. Blood specimens were taken from the subjects for gene detection purposes via conventional polymerase chain reaction. Sera specimens were used to run enzyme linked immunosorbent assay to measure the level of IFNγ.
Results: The age of subjects ranged from 32 to 63 years with no significant difference between mean ±SE of cases (46.822±1.087 years) with the mean ±SE (47.044 ±1.162 years) of the control subjects (P = 0.999). The mean ±SE of free T3 and T4 levels was lower in cases in comparison to those of controls, while the mean ±SE of TSH level in cases was significantly higher compared to those of controls. Statistically there was a highly significant difference in the mean ±SE of free T3, free T4 and TSH levels between cases and controls (P <0.001). Furthermore, the mean ±SE of anti-TPO, anti-Tg and IFNγ levels was higher in cases compared to those of control subjects. Statistical analysis shows a highly significant difference between mean ±SE of anti-TPO and anti-Tg antibody levels of cases compared to those of controls (P <0.001). As for IFNγ level, there was a significant difference between mean±SE of IFNγ levels in cases and controls (P = 0.021). The conventional polymerase chain reaction results showed that 39/45 (86.7%) of cases were tested positive for HLA-DRB1*04, while only 20/45 (44.04 %) of the control subjects tested positive for the gene, statistical analysis revealed a highly significant association between the existence of the gene with HT disease (P <0.001).
Conclusion: The study revealed a highly significant association between the existence of HLA-DRB1*04 gene and Hashimoto's thyroiditis disease among the Iraqi-Kurdish population in Erbil Province.
Caturegli P, De Remigis A, Chuang K, Dembele M, Iwama A, Iwama S. Hashimoto's thyroiditis: celebrating the centennial through the lens of the Johns Hopkins hospital surgical pathology records. J Thyroid Res. 2013; 23(2):142–50. https://doi:org/10.1089/thy.2012.0554
Baretić M. [100 years of Hashimoto thyroiditis, still an intriguing disease]. Acta Med Croatica. 2011; 65(5):453–7.
Ralli M, Angeletti D, Fiore M, D'Aguanno V, Lambiase A, Artico M, et al. Hashimoto's thyroiditis: An update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. J Autoimmunity Reviews. 2020:102649. https://doi.org/10.1016/j.autrev.2020.102649
Ajjan RA, Weetman AP. The pathogenesis of Hashimoto’s thyroiditis: further developments in our understanding. Horm Metab Res. 2015; 47(10):702–10. https://doi.org/10.1055/s-0035-1548832
Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune thyroid disorders. J Autoimmunity Reviews. 2015; 14(2):174–80. https://doi.org/10.1016/j.autrev.2014.10.016
Zaletel K, Gaberšček S. Hashimoto's Thyroiditis: From Genes to the Disease. Curr Genomics. 2011; 12(8):576-88. https://doi.org/10.2174%2F138920211798120763
Doniach D, Roitt IM. Auto-immunity in Hashimoto's disease and its implications. J Clin Endocrinol Metab. 1957; 17(11):1293–304. https://doi.org/10.1210/jcem-17-11-1293
Fröhlich E, Wahl R. Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases. Front Immunol. 2017; 8:52. https://doi.org/10.3389/fimmu.2017.00521
Brčić L, Barić A, Gračan S, Torlak V, Brekalo M, Škrabić V, et al. Genome-wide association analysis suggests novel loci underlying thyroid antibodies in Hashimoto’s thyroiditis. Sci Rep. 2019; 9(1):5360. https://doi.org/10.1038/s41598-019-41850-6
Radetti G. Clinical aspects of Hashimoto's thyroiditis. Endocr Dev. 2014; 26:158–70. https://doi.org/10.1159/000363162
Higgins V, Patel K, Kulasingam V, Beriault D, Rutledge A, Selvaratnam R. Analytical performance evaluation of thyroid-stimulating hormone receptor antibody (TRAb) immunoassays. Clin Biochem. 2020; 86:56–60. https://doi.org/10.1016/j.clinbiochem.2020.08.007
Ma S, Wu J, Wu J, Wei Y, Zhang L, Ning Q, et al. Relationship between HLA-DRB1 allele polymorphisms and familial aggregations of hepatocellular carcinoma. Curr Oncol. 2016; 23(1):e1–7. https://doi.org/10.3747/co.23.2839
Al-Hashimi AM. Thyroid Nodules in Baghdad, Iraq: A Personal Experience. Int J Sci Res. 2015; 4(7):588–9.
Pyzik A, Grywalska E, Matyjaszek-Matuszek B, Roliński J. Immune disorders in Hashimoto's thyroiditis: what do we know so far? J Immunol Res. 2015; 2015:979167. https://doi.org/10.1155/2015/979167
Desai MK, Brinton RD. Autoimmune Disease in Women: Endocrine Transition and Risk Across the Lifespan. Front Endocrinol (Lausanne). 2019; 10:265. https://doi.org/10.3389%2Ffendo.2019.00265
AngumF, Khan T, Kaler J, Siddiqui L, Hussain A. The Prevalence of Autoimmune Disorders in Women: A Narrative Review. Cureus. 2020; 12(5):e8094. https://doi.org/10.7759/cureus.8094
Siriweera EH, Ratnatunga NV. Profile of Hashimoto's Thyroiditis in Sri Lankans: Is There an Increased Risk of Ancillary Pathologies in Hashimoto's Thyroiditis? J Thyroid Res. 2010; 2010:124264. https://doi.org/10.4061/2010/124264
de Freitas CU, Grimaldi Campos RA, Rodrigues Silva MAF, Panachão MRI, de Moraes JC, Waissmann W, et al. Can living in the surroundings of a petrochemical complex be a risk factor for autoimmune thyroid disease?Environ. 2010; 110(1):112–7. https://doi.org/10.1016/j.envres.2009.10.009
Kust D, Matesa N. The impact of familial predisposition on the development of Hashimoto's thyroiditis. Acta Clin Belg. 2020; 75(2):104–8. https://doi.org/10.1080/ 17843286.2018.1555115
Kawasaki M, Ito M, Danno H, Kousaka K, Nakamura T, Yoshioka W, et al. The association between thyroid hormone balance and thyroid volume in patients with Hashimoto thyroiditis. Endocr J. 2019; 66(9):763–8.https://doi.org/10.1507/endocrj.ej19-0063
Abdullah YJ, Essa RH, Jumaa MG. Association of Hashimotoʼs Thyroiditis with IRGM Snps (Rs13361189 T/C, Rs4958847 G/A, And Rs10065172 C/T) In Iraqi Arab Patients. Nveo. 2021:5441–53.
Álvarez-Sierra D, Marín-Sánchez A, Ruiz-Blázquez P, de Jesús Gil C, Iglesias-Felip C, González Ó, et al. Analysis of the PD-1/PD-L1 axis in human autoimmune thyroid disease: Insights into pathogenesis and clues to immunotherapy associated thyroid autoimmunity. J Autoimmun. 2019; 103:102285. https://doi.org/10.1016/j.jaut.2019.05.013
Bossowski A, Harasymczuk J, Moniuszko A, Bossowska A, Hilczer M, Ratomski K. Cytometric evaluation of intracellular IFN-γ and IL-4 levels in thyroid follicular cells from patients with autoimmune thyroid diseases. J Thyroid Res. 2011; 4(1):13. https://doi.org/10.1186/1756-6614-4-13
Tomer Y. Hepatitis C and interferon induced thyroiditis. J Autoimmun. 2010; 34(3):J322–6. https://doi.org/10.1016/j.jaut.2009.11.008
Wysocki T, Olesińska M, Paradowska-Gorycka A. Current Understanding of an Emerging Role of HLA-DRB1 Gene in Rheumatoid Arthritis-From Research to Clinical Practice. Cells. 2020; 9(5). https://doi.org/10.3390/cells9051127
Scally SW, Petersen J, Law SC, Dudek NL, Nel HJ, Loh KL, et al. A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis. J Exp Med. 2013; 210(12):2569–82. https://doi.org/10.1084/jem.20131241
Tobón GJ, Youinou P, Saraux A. The environment, geo-epidemiology, and autoimmune disease: Rheumatoid arthritis. J Autoimmun. 2010; 35(1):10–4. https://doi.org/10.1016/j.jaut.2009.12.009
Matzaraki V, Kumar V, Wijmenga C, Zhernakova A. The MHC locus and genetic susceptibility to autoimmune and infectious diseases. Genome Biol. 2017. 18; 76. https://doi.org/10.1186/s13059-017-1207-1
Kokaraki G, Daniilidis M, Yiangou M, Arsenakis M, Karyotis N, Tsilipakou M, et al. Major histocompatibility complex class II (DRB1*, DQA1*, and DQB1*) and DRB1*04 subtypes' associations of Hashimoto's thyroiditis in a Greek population. Tissue Antigens. 2009; 73(3):199–205. https://doi.org/10.1111/j.1399-0039.2008.01182.x
Ramgopal S, Rathika C, Padma MR, Murali V, Arun K, Kamaludeen MN, et al. Interaction of HLA-DRB1* alleles and CTLA4 (+49 AG) gene polymorphism in Autoimmune Thyroid Disease. Gene. 2018; 642:430–8. https://doi.org/10.1016/j.gene.2017.11.057
Cho WK, Jung MH, Choi EJ, Choi HB, Kim TG, Suh BK. Association of HLA alleles with autoimmune thyroid disease in Korean children. Horm Res Paediatr. 2011; 76(5):328–34. https://doi.org/10.1159/000331134
Petrone A, Giorgi G, Mesturino CA, Capizzi M, Cascino I, Nistico L, et al. Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto's thyroiditis in an Italian population. Thyroid. 2001; 11(2):171–5. https://doi.org/10.1089/105072501300042901
Zeitlin AA, Heward JM, Newby PR, Carr-Smith JD, Franklyn JA, Gough SCL, et al. Analysis of HLA class II genes in Hashimoto's thyroiditis reveals differences compared to Graves’ disease. Genes & Immunity. 2008; 9(4):358–63. https://doi.org/10.1038/gene.2008.26
Ueda S, Oryoji D, Yamamoto K, Noh JY, Okamura K, Noda M, et al. Identification of independent susceptible and protective HLA alleles in Japanese autoimmune thyroid disease and their epistasis. J Clin Endocrinol Metab. 2014; 99(2):E379–83. https://doi.org/10.1210/jc.2013-2841
How to Cite
Copyright (c) 2023 Bakhtawar Ziad Omer, Sahar Mohammed Zaki Abdullah (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The copyright on any article published in Zanco J Med Sci is retained by the author(s) in agreement with the Creative Commons Attribution Non-Commercial ShareAlike License (CC BY-NC-SA 4.0).